09 July 2021>: Clinical Research
Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China
Chunmei Ye 12BCEF* , Weiwei Chen 3EF* , Qi Gao 12B , Yanxia Chen 4B , Xiaolu Song 5B , Sujie Zheng 2C* , Jinlin Liu 2AEG*DOI: 10.12659/MSM.930241
Med Sci Monit 2021; 27:e930241
Table 6 Multivariate analysis of secondary immunodeficiency in patients with multiple myeloma (MM) and matched MM patients.
Variable | Hazard ratio | 95% Confidence interval | P value |
---|---|---|---|
Hypogammaglobulinemia (IgG | 0.335 | 0.197–0.571 | |
Sex (Male vs Female) | 0.516 | 0.288–0.922 | 0.026 |
Albumin (≤3.5 g/dL vs >3.5 g/dL) (146 cases available) | 0.443 | 0.241–0.815 | 0.009 |